Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea · Delayed Price · Currency is KRW 6,310.00
-120.00 (-1.87%)
Last updated: Sep 2, 2026, 2:34 PM KST
Kwang Dong Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 87,403 | 140,991 | 116,189 | 77,344 | 103,552 | 83,966 |
Short-Term Investments | - | -0 | - | - | - | 9,369 |
Trading Asset Securities | 90,300 | 86,698 | 49,261 | 128,837 | 105,080 | 94,366 |
Cash & Short-Term Investments | 177,703 | 227,690 | 165,450 | 206,181 | 208,632 | 187,701 |
Cash Growth | -8.68% | 37.62% | -19.75% | -1.18% | 11.15% | 25.74% |
Accounts Receivable | 290,927 | 274,958 | 270,639 | 256,830 | 224,530 | 237,863 |
Other Receivables | 4,299 | 4,664 | 3,773 | 5,513 | 2,734 | 3,568 |
Receivables | 297,454 | 280,623 | 276,052 | 262,402 | 227,311 | 241,486 |
Inventory | 218,473 | 203,574 | 217,247 | 188,643 | 161,410 | 152,493 |
Prepaid Expenses | 1,799 | 1,866 | 2,350 | 1,766 | 2,017 | 2,370 |
Other Current Assets | 7,300 | 3,879 | 55,762 | 6,432 | 6,376 | 3,769 |
Total Current Assets | 702,729 | 717,631 | 716,862 | 665,424 | 605,747 | 587,818 |
Property, Plant & Equipment | 261,595 | 269,462 | 249,038 | 212,432 | 153,532 | 138,013 |
Long-Term Investments | 136,687 | 143,777 | 114,011 | 96,139 | 93,686 | 83,604 |
Goodwill | 35,966 | 27,875 | 21,694 | 21,694 | 6,119 | 6,119 |
Other Intangible Assets | 21,648 | 21,266 | 15,941 | 15,008 | 9,975 | 10,592 |
Long-Term Deferred Tax Assets | 20,606 | 15,969 | 14,154 | 12,960 | 10,536 | 8,365 |
Long-Term Deferred Charges | 6.07 | 10.05 | - | - | - | - |
Other Long-Term Assets | 130,396 | 121,774 | 37,760 | 52,214 | 50,247 | 46,982 |
Total Assets | 1,310,403 | 1,320,329 | 1,170,275 | 1,078,065 | 932,024 | 883,845 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 209,644 | 192,219 | 169,802 | 171,051 | 174,051 | 153,527 |
Accrued Expenses | 3,272 | 3,040 | 1,871 | 1,862 | 1,691 | 1,079 |
Short-Term Debt | 211,163 | 210,475 | 208,940 | 187,834 | 113,006 | 93,006 |
Current Portion of Long-Term Debt | 20,230 | 20,760 | 2,472 | 24,202 | - | 15,000 |
Current Portion of Leases | 7,604 | 7,529 | 3,128 | 1,913 | 1,362 | 1,109 |
Current Income Taxes Payable | 2,279 | 14,114 | 8,186 | 8,941 | 8,338 | 10,179 |
Current Unearned Revenue | 228.34 | 309.4 | 310.94 | 291.6 | 331.8 | 331.4 |
Other Current Liabilities | 69,730 | 77,474 | 66,589 | 60,714 | 54,786 | 51,263 |
Total Current Liabilities | 524,151 | 525,920 | 461,299 | 456,810 | 353,567 | 325,495 |
Long-Term Debt | 54,133 | 54,683 | 66,444 | 19,028 | 21,962 | 21,934 |
Long-Term Leases | 7,798 | 9,760 | 4,938 | 2,664 | 1,675 | 997.64 |
Long-Term Unearned Revenue | - | 356.37 | - | - | - | - |
Pension & Post-Retirement Benefits | 7,844 | 0 | -0 | 0 | -0 | -0 |
Long-Term Deferred Tax Liabilities | 5,049 | 5,168 | 4,440 | 2,173 | 1,675 | 2,717 |
Other Long-Term Liabilities | 6,421 | 12,645 | 14,888 | 9,344 | 6,099 | 5,457 |
Total Liabilities | 605,396 | 608,533 | 552,008 | 490,018 | 384,978 | 356,600 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 52,421 | 52,421 | 52,421 | 52,421 | 52,421 | 52,421 |
Additional Paid-In Capital | 70,894 | 70,802 | 58,171 | 55,299 | 55,277 | 55,223 |
Retained Earnings | 528,905 | 540,134 | 520,907 | 485,155 | 453,838 | 433,215 |
Treasury Stock | -607.4 | -12,074 | -57,124 | -53,057 | -46,822 | -46,822 |
Comprehensive Income & Other | -12,939 | 4,297 | 4,747 | 4,798 | 2,616 | 5,140 |
Total Common Equity | 638,673 | 655,579 | 579,122 | 544,616 | 517,331 | 499,177 |
Minority Interest | 66,334 | 56,217 | 39,145 | 43,431 | 29,716 | 28,068 |
Shareholders' Equity | 705,007 | 711,796 | 618,267 | 588,047 | 547,046 | 527,245 |
Total Liabilities & Equity | 1,310,403 | 1,320,329 | 1,170,275 | 1,078,065 | 932,024 | 883,845 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 300,928 | 303,208 | 285,921 | 235,641 | 138,006 | 132,046 |
Net Cash (Debt) | -123,225 | -75,518 | -120,471 | -29,460 | 70,627 | 55,655 |
Net Cash Growth | - | - | - | - | 26.90% | 40.66% |
Net Cash Per Share | -2702.13 | -1876.71 | -3008.73 | -727.94 | 1719.22 | 1353.21 |
Filing Date Shares Outstanding | 50.15 | 49.66 | 39.34 | 40.08 | 41.08 | 41.08 |
Total Common Shares Outstanding | 50.15 | 49.66 | 39.34 | 40.08 | 41.08 | 41.08 |
Working Capital | 178,577 | 191,711 | 255,563 | 208,615 | 252,180 | 262,323 |
Book Value Per Share | 12735.89 | 13201.09 | 14719.33 | 13588.02 | 12593.06 | 12151.16 |
Tangible Book Value | 581,059 | 606,438 | 541,487 | 507,915 | 501,237 | 482,467 |
Tangible Book Value Per Share | 11586.99 | 12211.56 | 13762.78 | 12672.32 | 12201.30 | 11744.38 |
Land | 64,419 | 65,001 | 62,710 | 74,423 | 65,921 | 65,840 |
Buildings | 193,389 | 193,949 | 150,395 | 95,003 | 77,283 | 75,616 |
Machinery | 189,914 | 185,876 | 157,259 | 152,469 | 129,099 | 124,756 |
Construction In Progress | 2,065 | 2,516 | 40,678 | 52,582 | 23,534 | 5,237 |